Interstitial Lung Disease 2 C5561926
A progressive lung condition causing inflammation and scarring of lung tissue. It affects breathing and oxygen intake. Treatment aims to slow progression and manage symptoms.
Key facts at a glance
- ICD-10
- J98.9
- ICD-11
- CA00.0
- Body system
- respiratory
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Dyspnea
(respiratory)Shortness of breath or cough
(respiratory)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dry cough
(respiratory)Low-grade fever
(respiratory)Digital clubbing
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-inflammatory and Immunosuppressive Therapy
Corticosteroids and immunosuppressants are used to reduce inflammation and slow disease progression in interstitial lung disease. Treatment response varies significantly among patients and depends on the underlying cause.
Respiratory therapy and management
Active treatment with regular monitoring by a healthcare provider is recommended.
Oxygen Therapy
Supplemental oxygen is provided to maintain adequate blood oxygen levels, reduce breathlessness, and improve exercise tolerance. Long-term oxygen therapy may be necessary as disease progresses.
Additional treatment options
Pulmonary Rehabilitation
Comprehensive program combining exercise training, breathing techniques, and education to improve lung function and quality of life. Includes supervised exercise sessions and self-management strategies.
physical_therapyDisease Progression Monitoring
Regular pulmonary function tests, imaging studies, and clinical assessments to track disease progression and treatment response. Allows for timely adjustments to management plans.
monitoringSmoking Cessation and Environmental Modification
Complete smoking cessation and avoidance of lung irritants including occupational dusts, air pollution, and secondhand smoke. Environmental modifications can significantly slow disease progression.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Interstitial Lung Disease 2 C5561926?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Interstitial Lung Disease 2 C5561926. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy